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RNA-cleaving DNAzymes have been attempted as in vivo analytical probes and gene silencing 
reagents over the last two decades. Despite progresses already achieved, concerns still exist 
regarding the activity of DNAzymes in biological fluids. An example is the low activity of the 
10-23 DNAzyme in intracellular Mg2+ concentrations. To obtain DNAzymes that work optimally 
in biological samples, we herein report the first DNAzyme in vitro selection in undiluted human 
blood serum. The selection starts with a large DNA library containing 50 random nucleotides, 
and sequences that can be cleaved in serum were isolated and amplified. After deep sequencing 
analysis, 80% of the final library are a variant of the 8-17 DNAzyme (named 17EV1). The main 
difference between 17E and 17EV1 is a single mutation at the N12 position of the catalytic core. 
17EV1 is ~6-fold faster in serum than 17E, since 17EV1 is preferentially activated by Ca2+ and 
serum is rich in Ca2+ over Mg2+. On the other hand, 17E has a similar activity with Ca2+ or Mg2+. 
With this observation, a method for measuring the Ca2+/Mg2+ ratio was developed by combining 
the 17E and 17EV1 DNAzymes. This study demonstrates the feasibility of selecting DNAzymes 
in biological fluids and will facilitate the application of DNAzymes in bioanalytical chemistry 
and gene therapy. 
 





DNA-based catalysts (DNAzymes) have found important analytical applications for metal 
detection in the last two decades.1 In particular, DNAzymes for RNA cleavage were used most 
often, which is attributable to their excellent metal specificity, catalytic activity, programmability, 
and stability.2-5 While most studies were focused on environmental metal analysis, in recent 
years we see a growing trend of using DNAzymes for biological samples, such as serum,6, 7 
cells,8-14 and cell extracts.15 
Ca2+ and Mg2+ are the most abundant metal ions in biological fluids, and they are critical 
in cell signaling, protein folding, and catalysis. Therefore, their detection has been a long-
standing topic of bioanalytical chemistry.16-18 However, using DNAzymes for their analysis was 
rarely explored.6, 7 DNAzymes might offer better metal selectivity, and using multiple 
DNAzymes, both ions might be detected simultaneously. In fact, using Mg2+-dependent 
DNAzymes for cleaving viral RNA has been proposed since 1994.19-21 In vitro DNAzyme 
selection using Ca2+ was also attempted.22 A lot of excitements were brought to the field by 
Santoro and Joyce in 1997, reporting two efficient DNAzymes that cleave full RNA with Mg2+.20 
In particular, the 10-23 DNAzyme was studied for intracellular RNA cleavage because of its 
excellent substrate generality.11 The 8-17 DNAzyme was researched more as a model biosensor.2  
However, concerns have been recently raised regarding the in vivo activity of these 
DNAzymes.23 For example, the 10-23 DNAzyme is hardly active with the physiological 
concentration of Mg2+ (<1 mM).24, 25 In contrast, most of their biochemical assays were carried 
out with 10-50 mM Mg2+. For both analytical and biomedical applications, obtaining highly 
active DNAzymes in physiological conditions is critical.   
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While many DNAzyme selections were carried out previously, most were performed in 
clean buffers with well-defined chemical compositions. We reason that improvement might be 
achieved by performing in vitro selections directly in target biological fluids. This idea has been 
used to obtain aptamers for cells and tissues under physiological and native conditions.26, 27 The 
closest examples for DNAzymes are probably the selections performed in bacterial cultures.28, 29 
We recently demonstrated that DNAzymes and their substrates have sufficient stability in 
serum.6 This might be related to DNA binding proteins in serum, which inhibit the activity of 
nucleases.30 This study also encouraged us to perform selections in serum. In this work, our 
primary goal was to test the feasibility of selecting DNAzymes in undiluted human blood serum. 
The secondary goal is to use the selected DNAzymes for the analysis of Ca2+ and Mg2+.  
 
Materials and methods 
Chemicals. The DNA samples for in vitro selection were from Integrated DNA Technologies 
(Coralville, IA), and the other DNAs were from Eurofins (Huntsville, AL). See Table S1 for the 
sequences and modifications of DNA. T4-DNA ligase, dNTP mix, Taq DNA polymerase and 
DNA ladder were from New England Biolabs. SsoFast EvaGreen supermix was from Bio-Rad. 
Tris(hydroxymethyl) aminomethane (Tris) and sodium chloride were from Mandel Scientific 
(Guelph, ON, Canada). All metal salts were from Sigma-Aldrich with the highest available 
purity. Human AB serum was from Mediatech (Manassas, VA, USA).  
In vitro selection. In vitro selection was performed following a previously published protocol 
with slight modifications.31 Briefly, the initial DNA pool was prepared by ligating Lib-FAM-N50 
(0.2 nmol) and Lib-rA (0.3 nmol) with splint DNA (0.3 nmol) using T4 ligase by following the 
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vendor’s protocol (see Table S1 for the sequence of DNA). After denaturing polyacrylamide gel 
electrophoresis (dPAGE) purification, this library was dissolved in 60 μL buffer A (50 mM MES, 
pH 6.0, 25 mM NaCl) with a DNA concentration of ~2.5 μM. For the first round of selection, 2 
μL of the DNA library was added to 10 μL human AB serum. The incubation time for each 
round is summarized in Table S2. The reaction was then quenched with 8 M urea with heating at 
80 °C for 3 min. The cleaved DNA sequences were separated by 10% dPAGE, desalted using a 
Sep-Pak column, and vacuum dried for PCR following reported previously conditions.31 The 
dried products were dissolved using human serum to initiate next round of selection. The round 8 
cleavage products were analyzed using deep sequencing. For the negative selections to eliminate 
the 17E DNAzyme, the PCR products were treated with a metal mixture containing 2.5 mM Ca2+ 
and 1 mM Mg2+ (selection A) or 10 μM Pb2+ (selection B). The uncleaved DNA was then 
harvested for the positive serum selection.  
Activity assays. To test DNAzyme activity in serum, FAM-labeled substrate (10 μM, FAM-Sub) 
and enzyme (20 μM, 17E or its variants) were annealed in buffer B (140 mM NaCl, 50 mM Tris, 
pH 7.5) to form DNAzyme complexes (See Table S1 for each DNA sequence). Then, 1 μL of the 
annealed complex was added to 9 μL serum to initiate the cleavage reaction. The reaction was 
quenched by transferring 2.5 μL of the reaction mixture to 14 μL urea (8 M) followed by heating 
at 80 °C for 3 min. The cleaved products were separated using 15% dPAGE gel and quantified 
by a ChemiDoc MP imaging system (Bio-Rad). To measure DNAzyme activity in buffer, the 
procedure was the same, except that dilution was made using buffer B instead of serum, and the 




Results and Discussion 
In vitro selection of DNAzymes in serum. So far, all known DNAzymes were obtained via in 
vitro selection. To select DNAzymes in serum, we used a protocol similar to the normal 
selections,31 except that undiluted human blood serum was used to induce cleavage without 
additional buffer or metal ions added. The selection library contained 50 random nucleotides, 
and this random region was positioned near the rA (ribo-adenine) by two short base-paired 
duplexes (Figure 1A). Note this rA is the only RNA nucleotide in this DNA library, serving as 
the cleavage site since RNA has much lower stability compared to DNA. See Figure S1 for the 
full library sequence. After added serum, active sequences that underwent self-cleavage were 
separated from the uncleaved DNA using gel electrophoresis, and amplified by two steps of PCR. 
The cleavage yield at each selection round was monitored (Figure 1B) and a significant jump 
was achieved at round 6. The round 8 library was deep sequenced, yielding 65,559 sequences.  
Interestingly, the library was dominated by two vary similar variants of the 8-17 
DNAzyme (denoted as 17EV1 and 17EV2, respectively). Figure 1C shows the general secondary 
structure of the 8-17 DNAzyme. 17EV1 and 17VE2 differ only by a single nucleotide at the N1 
position, which is for substrate binding. Therefore, they are essentially the same enzyme. 
Statistical analysis revealed that 17EV1 and 17EV2 are about equally populated (each ~40% of 
the final library, Figure 1D). For the remaining 20%, we tested 18 representative sequences in 
their trans-cleaving forms (Table S1, New1-18), but none was active (Figure S2). If we disregard 
the difference between 17EV1 and 17EV2, they differ from 17E only in two aspects: 1) the base 




Figure 1. (A) A scheme of an in vitro selection cycle in serum. The cleavage step (step 1) is 
carried out by dissolve the DNA library in serum followed by incubation. The cleaved library is 
harvested using PAGE and amplified by two steps of PCR. The ‘F’ label in P3 denotes for a 
carboxyfluorescein (FAM) fluorophore. The black diamond in P4 is a polymer spacer to stop 
polymerase extension so that this strand is longer and can be removed after PAGE at step 5. (B) 
The yield of cleavage for each selection round. (C) The general trans-cleaving structure of the 
17E DNAzyme. The difference between 17E and 17EV1/17EV2 are tabulated. The arrowhead 
indicates the cleavage site. (D) Sequence distribution in the final library. 
 
We recently reported activity of the 17E DNAzyme in undiluted serum.6 Therefore, it is 
not surprising that variants of 17E were selected here. In fact, 17E variants have been isolated 
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from many previous selections using different metal ions,20, 22, 32-34 which is attributed to its small 
size, tolerance to mutation, and high activity.35, 36 Unlike previous selections done in clean 
buffers, serum contains many other chemicals (e.g. proteins, nucleic acids, and small molecules). 
From our results, these chemicals did not play a major role in directing the selection outcome 
using the current library design.  
To test whether it is possible to eliminate 17E, we also performed extensive negative 
selections (Figure S3). In one attempt, the library was incubated with Pb2+ for negative selection 
(sequences cleaved with Pb2+ were discarded), since Pb2+ is very efficient in cleaving 17E.37 In 
another attempt, a mixture of Ca2+ and Mg2+ was used for negative selection. In some rounds, up 
to four consecutive negative selections were performed before the positive serum selection. 
However, the resulting DNAzymes were still mainly the 17E variants (data not shown). 
Therefore, this study adds another example supporting the isolation of 17E under physiological 
conditions. It does not mean 17E is the only solution for activity in serum, but because of its 
properties mentioned above, it is easy to dominate the library. It might be possible to avoid 17E 
by using other cleavage junctions,38 or by labeling fluorophore/quencher near the cleavage 
junction.39 
Activity of the 17E variants in serum. To rationalize our selection results, we tested the 
activity of these two variants in serum. Both 17EV1 and 17EV2 achieved a similar cleavage rate 
of 0.14 min-1 and 0.15 min-1, respectively (Figure 2A). This is expected since they differ only at 
the non-essential N1 position. In contrast, the 17E DNAzyme was 6-fold slower (0.025 min
-1). 
We previously reported 0.04 min-1 for 17E in serum,12 and this slight variation is attributed to a 
lower DNAzyme concentration used here. This activity assay also partially explains the 
appearance of 17EV1 and 17EV2 instead of 17E. Although we did not isolate a completely new 
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DNAzyme, our selection has improved the enzyme activity by 6-fold in the serum. This study 
also supports the feasibility of in vitro DNAzyme selection in serum.   
 
Figure 2. Kinetics of substrate cleavage by the three DNAzymes in (A) serum and (B) buffer 
(2.5 mM Ca2+, 1.1 mM Mg2+, 50 mM pH 7.5 Tris). (C) Cleavage rates of the three DNAzymes in 
serum and the buffer. Cleavage kinetics of the 17EV1 and 17E DNAzymes in presence of (D) 
2.5 mM Ca2+ or (E) 1.1 mM Mg2+. (F) Cleavage rate comparison of 17EV1 and 17E in presence 
of 2.5 mM Ca2+, 1.1 mM Mg2+ or 2.5 mM Ca2+ plus 1.1 mM Mg2+. 
 
Activity of 17E variants in buffer. To rationalize the rate difference of the 17E variants in 
serum, we also measured their activity in buffer. We prepared buffers to mimic the serum metal 
composition, containing 142 mM NaCl, 2.5 mM Ca2+ and 1.1 mM Mg2+.6 Similarly, no 
significant difference was observed in the activity of 17EV1 (0.44 min-1) and 17EV2 (0.50 min-1) 
(Figure 2B, C), but both variants were ~3-fold faster in the buffer than in serum. The slower rate 
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in serum might be caused by DNA binding proteins in serum (e.g. some proteins can bind 
guanine-rich DNA),6, 40 or by proteins sequestering metal ions.  
Since the above buffer contained both Ca2+ and Mg2+, we next studied each metal ion 
individually to dissect the effect. Since 17EV1 and 17EV2 are quite similar, only 17EV1 was 
studied. In the presence of 2.5 mM Ca2+, a rate of 0.52 min-1 was observed for 17EV1, 4.3-fold 
faster than 17E (0.12 min-1, Figure 2D), consistent with the result in serum. For comparison, 
17EV1 was 0.007 min-1 in 1.1 mM Mg2+, 6-fold slower than 17E (Figure 2E). This result is very 
interesting; the mutation from T12 to A12 in the catalytic core inverted the selectivity for Ca
2+ and 
Mg2+. Mutating T12 to A12 increases the Ca
2+ activity but decreases the Mg2+ activity. Serum has 
a higher Ca2+ concentration and thus the DNAzyme activity in serum is dominated by Ca2+. This 
difference might provide a way for measuring both metal ions using a ratiometric method.  
Since 17E is active with many divalent metal ions, an interesting question is the activity 
difference caused by this N12 position using other metal ions. It was previously reported that with 
this position being an adenine, the activity is optimal with Cd2+, Zn2+ and Mn2+.34 We measured 
the activity of 17E and 17EV1 in the presence of Pb2+, Zn2+, Mn2+, Co2+, Cd2+, Fe2+, Ni2+, Ca2+, 
Mg2+, Sr2+, Ba2+, Cu2+ and Ce3+. Aside from Ca2+, only Cd2+ and Pb2+ showed better activity for 
17EV1 than 17E, while the activity with Sr2+, Ba2+, Cu2+, and Ce3+ were too low to compare 
(Figure S4). Earlier studies pointed out that the N12 position plays two crucial roles in 17E.
41 
First, it acts as spacer between the short stem and the conserved C13 to ensure that C13 is at the 
most adequate position to carry out the catalytic function. In addition, N12 acts as a chaperon to 
correct folding of the DNAzyme.41 Charge density, ionic radius and coordination pattern of 
difference metal ions may contribute to the observed difference.  
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To understand the contribution of each metal to activity, we then compared the 
DNAzymes activity in the presence of Ca2+, Mg2+ and the mixture of Ca2+ plus Mg2+ (Figure 2F). 
For 17EV1, the fastest cleavage was achieved with 2.5 mM Ca2+ alone. After adding Mg2+, the 
cleavage rate even reduced slightly. This is explained the competition from the catalytically less 
capable Mg2+ (slower by 75-fold). Since Mg2+ has a higher charge density, Mg2+ competes 
favorably with Ca2+ for the metal binding site and decreases the rate. For 17E, on the other hand, 
Ca2+ and Mg2+ display an additive effect on activity. Although the cleavage rate for Mg2+ is 
lower than Ca2+, the difference is quite small (Ca2+ is only 2.8-fold faster). Since the apparent Kd 
of 17E for Mg2+ and Ca2+ is 15 mM and 8 mM, respectively,42 at low mM metal concentration, 
they both contribute to cleavage activity.  
The Peracchi group reported that the 8-17 DNAzyme and most of its variants are more 
active in Ca2+ (by 10 to 20-fold) than in Mg2+.43 In our work, the rate of 17EV1 was 75-fold 
faster for Ca2+, and this is due to a higher Ca2+ (2.5 mM) used than Mg2+ (1.1 mM). In addition, 
Peracchi also found that the relative activity between Ca2+ and Mg2+ was influenced by 
nucleotides from N12 to N15 (Figure 1C). The best preferential activation by Ca
2+ was obtained 
when these positions are ACGA, which is consistent with our results. They further demonstrated 
that the N12 position plays an important role in metal specificity.
44 For example, changing T12 to 
other nucleotides has only a moderate effect on the Ca2+-dependent activity, while the Mg2+-
dependent activity is more affected. We also observed a significant influence of N12 on metal 
activity and selectivity (Figure S4). The new information we obtained from this study includes 




In addition to their difference at the N12 position, their stem sequence (Figure 1C in 
purple) is also different. To ensure our above observations are indeed due to the N12 position, we 
made a single A12T mutation to 17EV1. This change has suppressed the Ca2+ activity but 
promoted the Mg2+ activity (Figure 3A). A similar observation was made based on 17E (Figure 
3B). With A12, both DNAzymes displayed better selectivity for Ca
2+ over Mg2+. Therefore, the 
base pair composition in the stem is less important for metal selectivity, and the key is the N12 
position. A previous report indicated that a three-G/C pair in the stem promotes activity due to 
higher stem stability.44 However, a different result was observed by the Li group, where 
sequences with different number of G/C pairs had comparable activity.33 Similar conclusions 
were also made by Kasprowicz et al in a recent report.34 With our observed metal preference in 
these 17E variants, we next aimed to test the feasibility of using these two related DNAzymes for 
the analysis of Ca2+ and Mg2+, which are two important physiological metal ions.  
 
Figure 3. Cleavage rates of (A) the 17EV1 and (B) the 17E DNAzymes in presence of 2.5 mM 
Ca2+, 1.1 mM Mg2+, or 2.5 mM Ca2+ plus 1.1 mM Mg2+ with the N12 position being an adenine 
or thymine. In this study, the red and green bars in each figure differ only at the N12 position. 




Ca2+/Mg2+ ratio measurement. Mg2+ and Ca2+ are two important and most abundant divalent 
cations in serum and they play crucial roles in a variety of biochemical processes. For example, 
Ca2+ participates in neurotransmitter releasing, gene transcription, and stimuli-mediated hormone 
secretion.45 Fluctuation of Ca2+ concentration is considered to be a barometer for diseases such 
as hyperparathyroidism.46 Mg2+ is important for signal transduction, protection against 
hypertension and blood vessel spasm.47 Various methods have been developed to measure Mg2+ 
and Ca2+.16-18 The concentrations of these two metal ions are quite different in different parts of 
the body. For instance, the concentration of Mg2+ is comparable in serum (~1.1 mM) or in cells 
(~1.6 mM). However, serum Ca2+ is about 2.5 mM while intracellular Ca2+ is only a trace 
amount (< 1 μM). Since both probes are active with both metals, it is difficult to measure their 
absolute concentrations. As a first step, we test the feasibility of measuring the Ca2+/Mg2+ 
concentration ratio, which is ~2.3 in serum and close to zero intracellularly. Therefore, this ratio 
can span >1000-fold in different samples.  
This study has provided a pair of 17E-based DNAzyme probes for such an application. 
To achieve ratiometric measurement, we chose 17E and 17EV1 since they show an opposite 
trend with Ca2+ and Mg2+. 17E is one of the most frequently used DNAzymes for Pb2+ 
detection.48-51 However, most biological samples do not contain free Pb2+ or other transition 
metal ions, leaving Mg2+ and Ca2+ as the most relevant metals for activating the DNAzymes.  
The activity of these two DNAzymes was first tested in present of the individual metal 
ions. Since for both DNAzymes, Ca2+ induced faster cleavage than Mg2+, and at the same Ca2+ 
concentration, 17EV1 is about 4-fold faster than 17E (Figure 2F), we used 20 min reaction time 
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for 17E while only 5 min for 17EV1 to ensure that cleavage yield is linearly proportional to Ca2+ 
concentration. Since the rate with Mg2+ is slower, for these time points with low mM Mg2+, the 
Mg2+ signal would not saturate the DNAzyme probes. 
Using these time points, Mg2+ and Ca2+ concentration-dependent cleavage was measured 
for both DNAzymes. When Mg2+ was tested, the data were fitted with a linear regression using 
equation A (Figure 4A). In this case, 17E had a more sensitive response to Mg2+ concentration, 
with a slope of 61%/mM Mg2+, which is 22-fold higher than that of 17EV1. On the other hand, 
the cleavage yield as a function of Ca2+ concentration was best fitted with a nonlinear equation B 
(Figure 4B). This is again due to the faster cleavage rates with Ca2+. Both 17EV1 and 17E 
showed a similar cleavage trend with increasing Ca2+ concentration (note their different reaction 
time). 
Based on the above observations, it seems feasible to determine the Ca2+/Mg2+ 
concentration ratio by using both DNAzymes. In our experimental conditions, since Ca2+ 
contributes similarly to cleavage of both 17E and 17EV1, the cleavage difference between 17E 
and 17EV1 is thus proportional to the fraction of Mg2+. With a higher content of Mg2+, a larger 
difference is expected (Figure 4A). To confirm this hypothesis, we test these two DNAzyme at 
various total metal concentrations, and at each concentration we tested different Ca2+/Mg2+ ratios 
(Figure 4C). Indeed, regardless of the total metal concentration, an increased 17EV1/17E 
cleavage ratio was observed with increasing Ca2+ percentage, and all these curves converge to 
the same line. We calculated the fitting parameters for each line (Table S3), from which we 




Figure 4. Fraction of substrate cleavage by 17E and 17EV1 with various concentrations of (A) 
Mg2+ and (B) Ca2+. The reaction time here was 20 min for 17E and 5 min for 17EV1. (C) Sensor 
calibration curves for Ca2+ molar percentage at various total metal ion concentrations. The 
overlapping of these curves indicates that the signal is insensitive to the total metal concentration 
but only to the fraction of Ca2+ in the mixture of Ca2+ and Mg2+. (D) Detection of Ca2+ 
percentage in various metal concentrations and a comparison with the theoretical results (the 
solid line). Each fitting equation is shown and all the parameters are in Table S3. 
 
Finally, to validate this method, we prepared a series of solutions with different total 
metal ion concentrations (0.3 mM, 0.5 mM and 0.7 mM, respectively). At each concentration, 
three Ca2+ percentage were prepared (30%, 50% and 70%). Then, both DNAzymes were tested 
with these solutions to calculate the 17EV1/17E cleavage ratios. Using the equation in Figure 4C, 
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the Ca2+ molar percentages were calculated and compared with the theoretical results (Figure 4D, 
the solid line). Within the error range, all the Ca2+ molar percentages analyzed by our method is 
on the solid line, indicating this method is suitable for the concentration ratio measurement. If 
this ratio indicates that the Ca2+ concentration is comparable or even higher than the Mg2+ 
concentration, we can estimate the absolute Ca2+ concentration from the 17EV1 cleavage yield 
since its Mg2+ response is very low. However, this estimation only works when the cleavage by 
Ca2+ is dominating. For example, it would not work for intracellular conditions. 
Overall, this pair of DNAzymes have demonstrated the possibility of measuring the ratio 
of these two important metal ions, but it is still far from ideal. For example, 17EV1 has a large 
difference between Ca2+ and Mg2+, while for 17E, this difference is quite small under our 
measurement condition. This has limited the accuracy and range of measurement. We only tested 
between 0.2-1 mM metal ions. By extending the incubation time, it might be possible to wider 
the measurement range to lower metal concentrations. In addition, it would be highly desirable to 
have enzymes specific for only one of the metals, which may allow us to quantify the absolute 
concentration instead of just the ratio. We obtained the current DNAzymes from in vitro 
selection in serum. We reason that a few strategies might help us to achieve better metal 
selectivity. For example, the library design can be changed (e.g. using different cleavage junction 
to avoid 17E).38 In addition, different selection conditions might be used (e.g. involving organic 
solvents),52 from which we might obtain new DNAzymes to fulfill this goal. 
Conclusions 
In summary, we carried out the first in vitro DNAzyme selection experiments in undiluted 
human blood serum. While we did not obtain completely new DNAzymes, the selection 
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experiment was a success, indicating the feasibility of DNA selection in biological fluids even 
though the library contains an RNA linkage. The resulting RNA-cleaving DNAzyme is a variant 
of 17E and it has nearly 6-fold higher activity in the presence of Ca2+ than the originally tested 
17E in serum.6 From the practical application standpoint, this study has also broadened the 
applicability of DNAzyme-based biosensor. Two active mutants were used and they display an 
opposite metal preference, allowing measurement of Ca2+ and Mg2+ concentration ratios, which 
has never been demonstrated before in the DNAzyme field. Currently, the detection was based 
on DNAzyme cleavage, which is irreversible. The fact that DNA can tell the difference between 
Ca2+ and Mg2+, two very similar metal ions, will inspire related work based on other sensing 
mechanisms. For example, DNA folding-based sensors might be developed to achieve reversible 
and faster detection of these important ions. 
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